Kadmon Holdings Inc.

07/19/2021 | Press release | Distributed by Public on 07/19/2021 05:07

Kadmon Announces Pivotal Trial Data Published in the Journal Blood for REZUROCK(TM) (Belumosudil) in Chronic Graft-Versus-Host Disease (cGVHD)